Prevalence of doravirine-associated resistance mutations in HIV-1-infected antiretroviral-experienced patients from two large databases in France and Italy
Articolo
Data di Pubblicazione:
2020
Citazione:
Prevalence of doravirine-associated resistance mutations in HIV-1-infected antiretroviral-experienced patients from two large databases in France and Italy / Soulie, Cathia; Santoro, Maria Mercedes; Storto, Alexandre; Abdi, Basma; Charpentier, Charlotte; Armenia, Daniele; Jary, Aude; Forbici, Federica; Bertoli, Ada; Gennari, William; Andreoni, Massimo; Mussini, Cristina; Antinori, Andrea; Perno, Carlo Federico; Calvez, Vincent; Ceccherini-Silberstein, Francesca; Descamps, Diane; Marcelin, Anne-Genevieve. - In: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. - ISSN 0305-7453. - 75:4(2020), pp. 1026-1030. [10.1093/jac/dkz553]
Abstract:
Doravirine, a novel NNRTI, selects for specific mutations in vitro, including mutations at reverse transcriptase (RT) positions 106, 108, 188, 227, 230 and 234. The aim of this study was to examine the prevalence of doravirine-associated resistance mutations in HIV-1-infected antiretroviral-experienced patients.
Tipologia CRIS:
Articolo su rivista
Elenco autori:
Soulie, Cathia; Santoro, Maria Mercedes; Storto, Alexandre; Abdi, Basma; Charpentier, Charlotte; Armenia, Daniele; Jary, Aude; Forbici, Federica; Bertoli, Ada; Gennari, William; Andreoni, Massimo; Mussini, Cristina; Antinori, Andrea; Perno, Carlo Federico; Calvez, Vincent; Ceccherini-Silberstein, Francesca; Descamps, Diane; Marcelin, Anne-Genevieve
Link alla scheda completa:
Pubblicato in: